Search
ZYTIGA 250 MG, Comprimé
Details
| --- | Description |
|---|---|
| Pack | Boite de 120 |
| Strength (Dosage) | 250 MG |
| Laboratory | MAPHAR |
| Ingredients | Abiratérone |
| Therapeutic class | Endocrinothérapie, autres antagonistes hormonaux et agents apparentés |
| ATC code | L02BX03 |
| PPH | $2,729.70 |
| PPV | $2,783.50 |
| Refundable | Yes |
| Refund base | $1,041.10 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Indiqué en association avec la prednisone ou la prednisolone dans : - le traitement du cancer métastatique de la prostate hormono-sensible (mHSPC) à haut risque nouvellement diagnostiqué chez les hommes adultes, en association avec un traitement par suppression androgénique (ADT). - le traitement du cancer métastatique de la prostate résistant à la castration (mCRPC) chez les hommes adultes asymptomatiques ou peu symptomatiques, après échec d’un traitement par suppression androgénique et pour lesquels la chimiothérapie n’est pas encore cliniquement indiquée. - le traitement du cancer métastatique de la prostate résistant à la castration (mCRPC) chez les hommes adultes dont la maladie a progressé pendant ou après une chimiothérapie à base de docétaxel. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem